Product Information
TRIAMCINOLONE 55 MCG NASAL SPR is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $0.7388 per ML under NDC 45802010901. Its NADAC has been published 457 times since Jan 3, 2018.
FDA first approved this application on Jul 30, 2009.
Strength
55 ug/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802010901
Classification
Generic
Dosage Form
SPRAY, METERED
Route
NASAL
Effective Date
9/23/2026
Active Ingredients
TRIAMCINOLONE ACETONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA078104FDA Approved
7/30/2009
On Market Since
3/28/2017
Pharmacological Classes
Price Statistics
The NADAC for TRIAMCINOLONE 55 MCG NASAL SPR has been published 457 times since Jan 3, 2018, and over the history we have for it it has declined 4.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7388 per ML |
|---|---|
| All-time high | $0.8093 (Mar 16, 2022) |
| All-time low | $0.6833 (Dec 19, 2018) |
| 52-week high | $0.7720 |
| 52-week low | $0.7136 |
| Median price | $0.7390 |
| Average price | $0.7431 |
| Largest weekly change | +12.8% (Oct 19, 2022) |
| Weeks tracked | 457 |
| Tracking since | Jan 3, 2018 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 2% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis Israel Pharmaceuticals Ltd manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Triamcinolone acetonide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRIAMCINOLONE 55 MCG NASAL SPR?
The current National Average Drug Acquisition Cost (NADAC) for TRIAMCINOLONE 55 MCG NASAL SPR, manufactured by Padagis Israel Pharmaceuticals Ltd, is $0.7388 per ML (NDC 45802010901), effective Sep 30, 2026.
How has the price of TRIAMCINOLONE 55 MCG NASAL SPR changed over time?
Over the history we have for it, the NADAC for TRIAMCINOLONE 55 MCG NASAL SPR has declined 4.9%. It has been tracked across 457 weekly CMS publications since Jan 3, 2018.
What are the highest and lowest recorded NADAC prices for TRIAMCINOLONE 55 MCG NASAL SPR?
Since Jan 3, 2018, the NADAC for TRIAMCINOLONE 55 MCG NASAL SPR has ranged from a low of $0.6833 (Dec 19, 2018) to a high of $0.8093 (Mar 16, 2022), with a median of $0.7390 per ML.
Are there cheaper alternatives to TRIAMCINOLONE 55 MCG NASAL SPR?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NASAL ALLERGY 24HR SPRAY, is $0.7229 per ML — about 2% below TRIAMCINOLONE 55 MCG NASAL SPR.
Who manufactures TRIAMCINOLONE 55 MCG NASAL SPR?
TRIAMCINOLONE 55 MCG NASAL SPR (NDC 45802010901) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.